Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 74.34% | 71.08% | 2,937.50% | 2,988.76% | -30.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.34% | 71.08% | 2,937.50% | 2,988.76% | -30.99% |
| Cost of Revenue | 52.89% | 50.14% | -8.60% | -6.44% | -19.35% |
| Gross Profit | 85.21% | 81.94% | 228.41% | 231.39% | -35.75% |
| SG&A Expenses | 42.68% | 40.01% | 26.42% | 29.35% | -34.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.07% | 21.74% | 29.13% | 32.17% | -4.61% |
| Operating Income | -16.81% | -14.63% | 31.20% | 29.60% | -0.96% |
| Income Before Tax | -19.59% | -17.34% | 27.68% | 25.99% | -0.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.59% | -17.34% | 27.68% | 25.99% | -0.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.59% | -17.34% | 27.68% | 25.99% | -0.86% |
| EBIT | -16.81% | -14.63% | 31.20% | 29.60% | -0.96% |
| EBITDA | -17.80% | -15.59% | 32.77% | 31.19% | -2.54% |
| EPS Basic | -50.00% | -50.00% | 50.00% | 50.00% | 50.00% |
| Normalized Basic EPS | -100.00% | -100.00% | 0.00% | 0.00% | 50.00% |
| EPS Diluted | -50.00% | -50.00% | 50.00% | 50.00% | 50.00% |
| Normalized Diluted EPS | -100.00% | -100.00% | 0.00% | 0.00% | 50.00% |
| Average Basic Shares Outstanding | 0.06% | 0.06% | 21.66% | 21.66% | 64.12% |
| Average Diluted Shares Outstanding | 0.06% | 0.06% | 21.66% | 21.66% | 64.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |